GRI logo

GRI
GRI Bio Inc

6,809
Mkt Cap
$3.41M
Volume
50,696.00
52W High
$311.36
52W Low
$2.10
PE Ratio
-0.01
GRI Fundamentals
Price
$2.36
Prev Close
$2.61
Open
$2.62
50D MA
$3.55
Beta
1.19
Avg. Volume
274,848.78
EPS (Annual)
-$121.80
P/B
0.20
Rev/Employee
$0.00
$7.48
Loading...
Loading...
News
all
press releases
News Placeholder
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits·2mo ago
News Placeholder
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga·3mo ago
News Placeholder
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com·9mo ago
<
...
1
>

Latest GRI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.